A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...

The formal reports of the work conducted by the MicroArray Quality Control (MAQC) consortium lay the groundwork for microarrays to gain acceptance as a clinical diagnostic and drug development tool.

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading DNA diagnostics companies' market shares, challenges, DNA diagnostics market ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...

Smartglasses are a new consumer-tech arms race for the last and best real estate on our bodies. So what are we supposed to do with them? Jackie Jantos, Hinge chief executive, details how the dating ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...

Washington’s move to unblock Anthropic’s model underscores America’s divisions over how to regulate cutting-edge technology. Several have joined the chorus of voices warning about the potential global ...

Generative artificial intelligence (GenAI) tools are challenging our understanding of plagiarism. How should we deal with plagiarism of ideas if this misbehaviour is increasingly common, and it is ...